P&G Health and medical consultants share medical steerage in the prognosis and therapy of nerve injury amongst diabetic sufferers
MANILA, Philippines, Nov. 11, 2022 /PRNewswire/ — Ahead of World Diabetes Day 2022, P&G Health, introduced collectively globally famend multidisciplinary medical consultants with Healthcare Professionals from throughout Asia-Pacific and the Middle East, at the ‘Winning the Fight Against Neuropathy in Diabetic Patients’ discussion board to share the newest medical steerage on diagnosing and treating diabetic nerve injury. Hosted out of Manila and simulcast to greater than 10 international locations and 3400 contributors, the signature occasion noticed the roll out of medical steerage on easy diagnostic process for peripheral neuropathy and sharing of medical experiences by medical consultants.
With Diabetes Mellitus being the main trigger[1] of peripheral neuropathy (PN), the growing prevalence of PN is carefully linked to the rise in the variety of diabetic sufferers. PN together with Diabetic Peripheral Neuropathy (DPN) is the results of injury to the nerves impacting high quality of life of individuals as they don’t seem to be in a position to go about their every day lives as comfortably. Burning and stabbing ache in the ft and palms can have a big impression on the actions of every day residing, together with strolling, climbing stairs, and sleeping. Peripheral neuropathy is commonly misdiagnosed or underdiagnosed on account of a lack of expertise amongst each sufferers and physicians[2]. Besides diabetes mellitus, B nutritional vitamins deficiencies and getting old are different high-risk elements resulting in peripheral nerve injury.
Dr Ashley Barlow, Senior Director, Medical & Technical Affairs, P&G Health (Asia Pacific, India, Middle East, and Africa) shared, “As a partner to International Diabetes Federation (IDF), P&G Health is committed to continued efforts to raise awareness on Diabetes and its associated complications including Peripheral Neuropathy and Nerve Damage. The ‘Winning the Fight Against Neuropathy in Diabetic Patients’ forum is the first of several scientific forums being rolled out by P&G Health as part of our World Diabetes Day awareness efforts across Asia Pacific, Middle East, and Africa region, to highlight the connection between Peripheral Neuropathy and Diabetes and the importance of early identification and timely treatment.”
Speaking at the discussion board, Dr. Rayaz A. Malik (Professor of Medicine at Weill Cornell Medicine, Consultant Physician at Central Manchester University Teaching Hospital) shared, “Peripheral neuropathy is highly underdiagnosed in South-East Asia and the Middle East due to a lack of consensus guidance on routine screening and diagnostic pathways. This has a major impact on the quality of life as a result of painful neuropathic symptoms, foot ulceration and amputation with an associated 5-year mortality of 40% and 80%, respectively. An awareness and sense of urgency amongst patients and healthcare providers is required, and primary care physicians need simple tools and guidance to help them diagnose peripheral neuropathy.”
The P&G Health ‘Winning the Fight Against Neuropathy in Diabetic Patients’ discussion board delivered to mild enriching insights, information and medical observe tips from well being consultants from throughout the globe and the area on the necessary function of neuropathy diagnoses, therapy and administration, in bettering the high quality of lifetime of diabetic sufferers,” added Dr. Ashley Barlow.
“While identifying a patient with early onset PN may sound challenging, it is not and doesn’t require complex diagnostic tools to diagnose peripheral neuropathy. Simple tools like a questionnaire and a sensory test can be a good start. By asking the right questions and listening to the patient, we can help patients avoid severe complications and improve their quality of life. The primary care physician has a key role to play in this,” added Dr. Rayaz A Malik.
For extra data on the ‘Winning the Fight Against Neuropathy in Diabetic Patients’ discussion board, click on right here to register and study from the webinar as healthcare skilled: WDDglobalwebinar
FAST FACTS
- In 2021, there have been 393 million diabetic sufferers in the Asia Pacific, the Middle East, and African areas projected to rise to 603 million by 2045[3].
- 1 in 2 sufferers with diabetes and endure from Peripheral Neuropathy[4] throughout their lifetime. With the growing prevalence of diabetes there might be an exponential progress in the variety of sufferers in these areas with PN.
- There are additionally no less than as many individuals with pre-diabetes as there are with diabetes and no less than 10% endure from PN[5].
- A examine from the Philippines in 2000 from the Diabcare-Asia venture, which assessed 2,708 sufferers in diabetes centres, reported a prevalence of 42% for diabetic neuropathy, based mostly on medical data[6].
- < 1/third of physicians acknowledge indicators of DPN. Undiagnosed circumstances contributing enormously to the excessive charges of morbidity and mortality of diabetes[3]. Up to 50 % of sufferers are asymptomatic and subsequently usually stay undiagnosed and are liable to insensate damage[7].
- If not recognized and handled early, DPN can manifest with neuropathic ache with an incredible impression on the high quality of life.
About P&G Health: P&G Health, the well being care division of P&G firm, drives consumer-centric innovation to empower our shoppers to dwell more healthy, and extra vibrant lives. The P&G Health portfolio contains main manufacturers in Respiratory with Vicks® and Nasivin®, Pregnancy with Femibion® and Clearblue®, Oral Care with Crest® and Oral-B®, Vitamins and Minerals Supplementation with Bion3®, Seven Seas®, Evion® and Sangobion®, Digestive wellness with Metamucil®, Prilosec OTC®, Pepto Bismol® and Align®, Nerve Care with Neurobion® and Pain Relief with Dolo-Neurobion®.
About Procter & Gamble: P&G serves shoppers round the world with considered one of the strongest portfolios of trusted, high quality, management manufacturers, together with Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G neighborhood contains operations in roughly 70 international locations worldwide.
References:
- Landmann G. Ars Medici. 2013;1: 18-21
- Malik, Rayaz et. al. Journal of Diabetes Investigation. 11. 10.1111/jdi.13269.
- International Diabetes Federation. IDF Diabetes Atlas. tenth version; 2021.
- Kumar S, et al. Laser Therapy 2016;25: 141–144
- Kirthi V et. al. BMJ Open Diabetes Res Care. 2021 May;9(1):e002040
- Lantion-Ang LC. Diabetes Res Clin Pract 2000; 50 (Suppl 2): S29–S34.
- Miranda-Massari JR, et al. Curr Clin Pharmacol. 2011;6: 260–273.
Photo – https://mma.prnewswire.com/media/1944556/PG2.jpg
Photo – https://mma.prnewswire.com/media/1944555/PG1.jpg
View unique content material:https://www.prnewswire.co.uk/news-releases/winning-the-fight-against-neuropathy-in-diabetic-patients-301675417.html
